The Fire Hose Problem: When Continuous Monitoring Overwhelms Episodic Care
Wearable health data refers to the continuous stream of physiological and behavioral measurements collected by consumer or medical devices worn on the body, which track signals such as heart rate, sleep, activity, stress, and other potential biomarkers, and which are intended to support health monitoring, early risk detection, and, ideally, clinical decision-making by healthcare professionals. Fitness bands, smartwatches, and rings now measure heart rate, blood pressure estimates, sleep stages, pulse oxygen, and more, quantifying daily life in near real time. More than 30% of adults own a fitness or wellness wearable, so the data volume is enormous. Yet most healthcare is still organized around episodic visits, not continuous monitoring biomarkers. Cardiologists like Dr. David Kao report that when patients arrive with months of charts, “probably 70% of it” has unclear clinical meaning. Doctors must decide, under time pressure, which numbers matter and which are marketing inventions.
Why Doctors Can’t Use Most Wearable Health Data
Clinical integration breaks down at several points. First, many metrics on consumer wearables—such as proprietary scores for strain, readiness, or recovery—lack clear definitions or published algorithms, so their validity is uncertain. Researchers warn that dismissing wearable-generated data can alienate engaged patients, but acting on questionable readings risks harm. Second, doctors do not have tools to turn raw streams into concise, clinically relevant views. A cardiologist may want to know if a patient had sustained irregular rhythms, not see every heartbeat for three months. Third, governance questions remain unresolved: what should be stored, for how long, and who is responsible for reviewing it? Health systems built for sparse, structured entries struggle with continuous monitoring biomarkers that arrive as noisy, unfiltered timelines rather than targeted test results.
Health Data Interoperability: EHRs, Clouds and the Wild West of Platforms
Health data interoperability is a major barrier between wearable health data and real clinical value. To move information from a smartwatch app into an electronic health record, separate cloud systems must communicate securely and match records to the right person. According to Dr. Ida Sim, “All of that is just a Wild, Wild West,” with providers juggling multiple logins and incompatible dashboards for each device brand. Even when data flows in, formats differ and units are inconsistent, so clinicians cannot compare metrics across platforms. Doctors must decide whether they need a heart-rate reading every five minutes or a summarized trend. Without shared standards, data schemas, and APIs, continuous monitoring biomarkers stay trapped in consumer apps, while EHRs remain islands of structured lab values and notes. Emerging integrations, like care orchestration platforms that plug into major EHR vendors, hint at a more connected future but are far from universal.
From Steps to Cortisol: New Biomarkers That Might Matter Clinically
Not all wearable metrics are equal in medical value. Step counts and generic “stress” scores may be motivational, but clinicians look for biomarkers tied to specific conditions and outcomes. Heart rhythm irregularities captured by wearables have already flagged suspected atrial fibrillation in at-risk patients, convincing some electrophysiologists of their potential. Continuous glucose monitors show how real-time data can be integrated and acted on in established care pathways. The next wave includes continuous monitoring biomarkers such as cortisol or more nuanced sleep-stage patterns, which could link daily physiology to mood disorders, metabolic risk, or cardiovascular strain. Yet these signals only help if devices measure them accurately, algorithms are published or independently tested, and the outputs map to clinical concepts like “elevated risk of arrhythmia” rather than vague wellness labels. Turning new biomarkers into standard-of-care tools will require rigorous trials and alignment with diagnostic criteria.
What Needs to Change for True Clinical Integration
For wearable health data to become routinely useful in medicine, three shifts are needed. First, strong data standards and health data interoperability must ensure that continuous monitoring biomarkers flow into EHRs in consistent, clinician-friendly formats with clear summaries and alerts instead of raw streams. Second, clinical validation initiatives—FDA pathways, independent accuracy testing, and peer-reviewed studies—must separate meaningful metrics from marketing features, giving doctors confidence in what they see. Third, workflow support is essential: AI tools could scan large volumes of wearable health data, highlight patterns relevant to a specific condition, and present a concise synopsis for the doctor as the human in the loop. As health systems experiment with linking operational EHRs to analytic platforms, the goal is to turn a digital avalanche into targeted insights that change diagnoses, treatments, and outcomes—not more noise in an already crowded visit.
